Cart
sales@molnova.com
Epicorynoxidine
CAS No. 58000-48-9
Epicorynoxidine( —— )
Catalog No. M29137 CAS No. 58000-48-9
Epicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 447 | Get Quote |
|
| 5MG | 773 | Get Quote |
|
| 10MG | 1031 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEpicorynoxidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.
-
DescriptionEpicorynoxidine is an alkaloid derived from the herbs of Corydalis tashiroi.(In Vitro):Epicorynoxidine shows cytotoxicity of P-388 cell lines with ED50 of 25.53 μg/mL.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number58000-48-9
-
Formula Weight371.433
-
Molecular FormulaC21H25NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc2CC[N@+]3([O-])Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Narchinol B
Narchinol B (Compound 4) is a sesquiter penoid compound. Narchinol B has anti-inflammatory effects. Narchinol B works by inhibiting proinflammatory mediators, including prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) proteins,as well as proinflammatory cytokines, such as interleukin-1b, IL-6, and tumor necrosis factor-α (TNF-α). Narchinol B significantly inhibits LPS-induced overproduction of NO in BV2 cells (IC50=2.43 μM).
-
petunidin-3-O-(6-O-p...
petunidin-3-O-(6"-O-p-coumaroyl)glucoside-5-O-diglucoside
-
Dextrothyroxine
Dextrothyroxine could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles.
